Nike Inc. (NKE) - 5i Research

Nike Inc. (NKE $64.49)
- $64.49 P/E (TTM): 32.99X Cap: $95.09B
- View NKE Profile
- View Questions on NKE

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Adobe Inc. (ADBE $320.67)
- $320.67 P/E (TTM): 20.37X Cap: $132.91B
- View ADBE Profile
- View Questions on ADBE
Accenture plc Class A (Ireland) (ACN $249.94)
- $249.94 P/E (TTM): 20.4X Cap: $163.12B
- View ACN Profile
- View Questions on ACN
Nike Inc. (NKE $64.49)
- $64.49 P/E (TTM): 32.99X Cap: $95.09B
- View NKE Profile
- View Questions on NKE
Thermo Fisher Scientific Inc (TMO $591.22)
- $591.22 P/E (TTM): 34.27X Cap: $222.88B
- View TMO Profile
- View Questions on TMO
TELUS Corporation (T $18.29)
- $18.29 Cap: $28.37B
- View T Profile
- View Questions on T
IDEXX Laboratories Inc. (IDXX $754.20)
- $754.20 P/E (TTM): 62.94X Cap: $60.36B
- View IDXX Profile
- View Questions on IDXX

Q: Dear 5i,

I have a diverse portfolio with stocks and ETFs. Most of my portfolio is doing well. Want to know your thoughts about a few of my holdings that are not doing so well - Adobe, Nike, Accenture, TMO, IDXX and Telus.

What are your thoughts? Should I replace these with a US ETF or hold on. Thanks for your valuable advice as always.

Read Answer Asked by Alka on November 26, 2025

Nike Inc. (NKE $64.49)
- $64.49 P/E (TTM): 32.99X Cap: $95.09B
- View NKE Profile
- View Questions on NKE
Dollarama Inc. (DOL $201.52)
- $201.52 P/E (TTM): 44.78X Cap: $55.95B
- View DOL Profile
- View Questions on DOL
lululemon athletica inc. (LULU $184.88)
- $184.88 P/E (TTM): 12.42X Cap: $20.64B
- View LULU Profile
- View Questions on LULU
Aritzia Inc. Subordinate Voting Shares (ATZ $111.53)
- $111.53 P/E (TTM): 46.41X Cap: $12.93B
- View ATZ Profile
- View Questions on ATZ
- View Reports on ATZ
Crocs Inc. (CROX $85.92)
- $85.92 P/E (TTM): 27.84X Cap: $4.43B
- View CROX Profile
- View Questions on CROX

Q: My total allocation in my portfolio is currently at 16%. However, it is inverse what the asset allocator recommend with nearly 4% in Cyclical and over 12% in Defensive. Would you recommend shifting some within Consumer? Do what extent does this matter since the boundary between both seems somewhat artificial? FYI - I own ABEV, BKGN, DOL, FDP, SAP all in my RRSP. If you recommend that I shift into Cons Cyclical, what would recommend as of today for my RRSP (US and CAN)?

Read Answer Asked by Patrik on October 14, 2025

Nike Inc. (NKE $64.49)
- $64.49 P/E (TTM): 32.99X Cap: $95.09B
- View NKE Profile
- View Questions on NKE
iShares U.S. Small Cap Index ETF (CAD-Hedged) (XSU $47.27)
- $47.27 P/E (TTM): 16.77X Cap: $660M
- View XSU Profile
- View Questions on XSU
lululemon athletica inc. (LULU $184.88)
- $184.88 P/E (TTM): 12.42X Cap: $20.64B
- View LULU Profile
- View Questions on LULU
Vanguard FTSE Developed ex North America High Dividend Yield Index ETF (VIDY $40.32)
- $40.32 P/E (TTM): 23.4X Cap: $1.05B
- View VIDY Profile
- View Questions on VIDY

Q: Are any of these above companies worth investing in? Also if so, at what price would be a good buy.

Thank You
John G.

Read Answer Asked by John on October 07, 2025